138 related articles for article (PubMed ID: 2347052)
1. Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil.
Ghavamzadeh A
Cancer Chemother Pharmacol; 1990; 26 Suppl():S66-8. PubMed ID: 2347052
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer.
Langenbuch T; Mross K; Jonat W; Hossfeld DK
Cancer Chemother Pharmacol; 1990; 26 Suppl():S93-6. PubMed ID: 2347058
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours.
Hoffmann W; Weidmann B; Migeod F; Könner J; Seeber S
Cancer Chemother Pharmacol; 1990; 26 Suppl():S69-70. PubMed ID: 2347053
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer.
Gurney H; Harnett P; Stuart-Harris R; Kefford R
Eur J Cancer; 1995 Oct; 31A(11):1773-7. PubMed ID: 8541098
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancer.
Becher R; Höfeler H; Kloke O; Kurschel E; Schilcher RB; Weinhardt O; Wandl U; Schmidt CG
Semin Oncol; 1989 Feb; 16(1 Suppl 3):56-9. PubMed ID: 2495568
[TBL] [Abstract][Full Text] [Related]
9. Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
Toma S; Coialbu T; Biassoni L; Folco U; Gatti C; Canavese G; Giacchero A; Rosso R
Cancer Chemother Pharmacol; 1990; 26(6):453-6. PubMed ID: 2121378
[TBL] [Abstract][Full Text] [Related]
10. Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
Colucci G; Romito S; Gebbia V; Pacilio G; Giotta F; Testa A; Pezzella G; Durini E; Agostara B; Cariello S
Br J Cancer; 1995 Nov; 72(5):1245-50. PubMed ID: 7577476
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide, methotrexate, and 5-fluorouracil: effective combination in resistant breast cancer.
Gad-el-Mawla N; Hamza MR; Zikri ZK; Elserafi M; el-Khodari A; Khaled H; Gafaar R
Cancer Chemother Pharmacol; 1990; 26 Suppl():S85-6. PubMed ID: 2347057
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin.
Gurney H; Harnett P; Kefford R; Boyages J
Aust N Z J Med; 1998 Jun; 28(3):400-2. PubMed ID: 9673758
[TBL] [Abstract][Full Text] [Related]
13. Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer.
Recchia F; De Filippis S; Rosselli M; Saggio G; Pompili P; Piccinini M; Rea S
Am J Clin Oncol; 2001 Aug; 24(4):392-6. PubMed ID: 11474271
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.
Kiraz S; Baltali E; Güler N; Barista I; Benekli M; Celik I; Güllü IH; Kars A; Tekuzman G; Firat D
J Chemother; 1996 Aug; 8(4):310-4. PubMed ID: 8873839
[TBL] [Abstract][Full Text] [Related]
15. Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer. Results of a prospective multicenter trial.
Lange OF; Scheef W; Haase KD; Heckmann M; Leyendecker R; Urban G; Zegners G
Cancer Chemother Pharmacol; 1990; 26 Suppl():S74-7. PubMed ID: 1693317
[TBL] [Abstract][Full Text] [Related]
16. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
Jäger E; Klein O; Wächter B; Bernhard H; Dippold W; Meyer zum Büschenfelde KH; Knuth A
Oncology; 1996; 53(1):58-63. PubMed ID: 8570133
[TBL] [Abstract][Full Text] [Related]
17. Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer.
Haas R; Schmid H; Hahn U; Hohaus S; Goldschmidt H; Murea S; Kaufmann M; Wannenmacher M; Wallwiener D; Bastert G; Hunstein W
Eur J Cancer; 1997 Mar; 33(3):372-8. PubMed ID: 9155519
[TBL] [Abstract][Full Text] [Related]
18. First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.
Ardavanis A; Tryfonopoulos D; Orphanos G; Ioannidis G; Karamouzis M; Rigatos G
Anticancer Res; 2005; 25(6C):4493-8. PubMed ID: 16334132
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.
J Clin Oncol; 1988 Apr; 6(4):679-88. PubMed ID: 2895801
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer.
Eisen T; Smith IE; Johnston S; Ellis PA; Prendiville J; Seymour MT; Walsh G; Ashley S
J Clin Oncol; 1998 Apr; 16(4):1350-7. PubMed ID: 9552036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
